
National Lung Cancer Screening Guidelines Insufficient for Minorities, Study Finds
Researchers recently evaluated data collected from a lung cancer screening program at the University of Illinois at Chicago (UIC) and compared results to the national lung cancer screening guidelines.
Researchers recently evaluated data collected from a lung cancer screening program at the University of Illinois at Chicago (UIC). The program provided evidence that the national lung cancer screening guidelines, which were developed based on the National Lung Screening Trial (NLST) in 2011, and recommend screening based on age and smoking history of individuals, may be insufficient for individuals in underrepresented communities.
The results, recently
“Immunotherapies and other advances in medicine have come a long way in extending life and improving the quality of life for many individuals diagnosed with lung cancer, but those advances mean much less for people living in underserved communities who can’t access or are ineligible for screening programs,” said senior author, Lawrence Feldman, MD, in a
“Screening that is offered based only on age and smoking history may miss a large group of people who are at risk due to other factors,” commented Feldman.
The cohort of patients studied by researchers at UIC were made up of 500 men and women whose mean age was 62 years and had received care at the UIC Hospital and Clinics or UI Health Mile Square Health Center.
Although lung cancer screening is effective, these data show that the guidelines should incorporate more expansive, risk-based screening in order to address racial disparities in lung cancer outcomes, said Mary Pasquinelli, UIC nurse practitioner and lead study author.
Reference
Pasquinelli M, Kovitz K, Koshy M, et al. Outcomes from a minority-based lung cancer screening program vs the national lung screening trial [published online August 2, 2018]. JAMA Oncol. doi:10.1001/jamaoncol.2018.2823.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.